Chemistry:EiPLA

From HandWiki

EiPLA, also known as N-ethyl-N-isopropyllysergamide or as lysergic acid ethylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).[1][2][3] It is an isomer of ETH-LAD.[3]

Interactions

Pharmacology

Pharmacodynamics

In drug discrimination tests in rodents, EiPLA was found to have approximately half the potency of LSD.[1][2][3]

Chemistry

Analogues

Analogues of EiPLA include MiPLA, LAMPA (MPLA), EPLA, EcPLA, and ETFELA, among others.

History

EiPLA was first described in the scientific literature by David E. Nichols and colleagues by at least 1994.[1] It appears to have emerged as a novel designer drug by 2019.[3]

See also

References

  1. ↑ 1.0 1.1 1.2 "Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives". Pharmacology, Biochemistry, and Behavior 47 (3): 667–673. March 1994. doi:10.1016/0091-3057(94)90172-4. PMID 8208787. 
  2. ↑ 2.0 2.1 "Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)". ACS Chemical Neuroscience 9 (10): 2331–2343. October 2018. doi:10.1021/acschemneuro.8b00043. PMID 29461039. 
  3. ↑ 3.0 3.1 3.2 3.3 "Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD)". Drug Testing and Analysis 16 (2): 187–198. February 2024. doi:10.1002/dta.3530. PMID 37321559. 

Template:Psychedelics



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:EiPLA&oldid=4178552"